Share on StockTwits
 

Equities researchers at Deutsche Bank began coverage on shares of Neutral Tandem (NASDAQ:TNDM) in a research report issued on Monday, Analyst Ratings Net reports. The firm set a “hold” rating and a $26.00 price target on the stock. Deutsche Bank’s price objective would suggest a potential upside of 4.88% from the stock’s previous close.

The analysts wrote, “We are initiating coverage of Tandem Diabetes (TNDM) with a Hold rating and a PT of $26. We see Tandem as an exciting story within the diabetes management space and believe the company is poised to capture share with its t:slim insulin pumps and next-generation products. TNDM’s IPO priced at $15.00 and since Nov 14, the stock has appreciated 65% to $24.79 (Dec 6 closing price). Thus, despite our positive view on the company’s fundamentals and its prospects, given the stock’s recent move we believe the stock is largely fairly valued at current levels.”

Separately, analysts at Piper Jaffray initiated coverage on shares of Neutral Tandem in a research note to investors on Monday. They set an “overweight” rating on the stock. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $27.67.

Shares of Neutral Tandem (NASDAQ:TNDM) opened at 24.79 on Monday. Neutral Tandem has a 52 week low of $18.61 and a 52 week high of $25.94. The stock’s 50-day moving average is $21.76 and its 200-day moving average is $21.76. The company’s market cap is $5.7 million.

Neutral Tandem, Inc provides tandem interconnection services principally to competitive carriers, including wireless, wireline, cable and broadband telephony companies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.